Skip to main content
. 2010 Dec 27;108(2):774–779. doi: 10.1073/pnas.1011845108

Fig. 2.

Fig. 2.

Ablation of Rarb suppresses ErbB2-induced mammary tumorigenesis. (A) Rarb−/− mice are resistant to mammary tumors induced by activated ErbB2 when expressed from its own promoter (n = 23 Rarb−/− and 42 wild-type mice). (B) Rarb−/− mice show a significant delay (P < 0.001 log-rank test) in tumor formation when the expression of ErbB2 is driven by the MMTV-LTR promoter (n = 30 Rarb−/− and 27 wild-type mice).